ClearVue Raises $746K to Fuel Global Solar Glass Ambitions

ClearVue Technologies has secured $746,574 through a mix of equity and debt to support its international commercialisation efforts amid shifting market conditions.

  • Raised $337K via At-Call Funding Facility by releasing 2 million shares
  • Secured $409K short-term loan backed by expected 2025 R&D rebate
  • Issued additional 10 million shares as collateral to Alpha Investment Partners
  • Adjusting strategic timeline due to market and regulatory factors
  • Maintaining diversified funding strategy to limit equity dilution
An image related to Clearvue Technologies Limited
Image source middle. ©

Funding Moves Amid Market Shifts

ClearVue Technologies Limited (ASX – CPV), a pioneer in solar glass technology, has taken decisive financial steps to underpin its global commercialisation plans. On 30 June 2025, the company announced it raised $337,400 through its At-Call Funding Facility with Alpha Investment Partners by releasing 2 million shares previously held as collateral. This move completes the initial 10 million shares allocated to Alpha, with a further 10 million shares now issued as additional collateral.

In parallel, ClearVue secured a $409,174 short-term secured loan from Radium Capital, backed by the research and development rebate it expects to receive later this year. The loan carries a 16% annual interest rate and matures at the end of 2025, providing immediate working capital and R&D funding.

Strategic Adjustments and Market Realities

CEO Martin Deil acknowledged the evolving market and regulatory environment necessitated adjustments to ClearVue's strategic timeline. Despite these external pressures, the company remains optimistic, progressing a pipeline of approximately 45 qualified international projects. The funding approach reflects a balance between maintaining operational flexibility and preserving shareholder value by avoiding significant equity dilution at current valuations.

ClearVue’s use of Alpha’s At-The-Market facility allows it to raise capital at prevailing market rates without committing to larger, potentially dilutive capital raises prematurely. Meanwhile, the secured loan from Radium Capital complements this strategy by diversifying funding sources and leveraging expected government incentives.

Positioning for Growth in Building Integrated Photovoltaics

ClearVue’s patented solar glass technology integrates energy generation into building surfaces such as windows and facades, positioning the company at the forefront of sustainable building materials. Since its ASX listing in 2018, ClearVue has expanded its global footprint through licensing partnerships and a robust intellectual property portfolio. The company aims to deliver practical net-zero energy solutions that address the pressing challenge of decarbonising the built environment.

While the current funding round is modest, it underscores ClearVue’s commitment to advancing commercialisation amid a competitive and evolving clean energy landscape. The company’s financial maneuvers suggest a cautious but confident approach to scaling operations and capitalising on growing demand for Building Integrated Photovoltaic (BIPV) solutions worldwide.

Bottom Line?

ClearVue’s latest funding round sets the stage for measured growth, but market conditions will dictate the timing of larger capital raises.

Questions in the middle?

  • How will the 16% interest on the Radium Capital loan impact ClearVue’s cash flow in 2025?
  • What specific regulatory changes have influenced ClearVue’s adjusted strategic timeline?
  • When might ClearVue pursue a larger capital raise to accelerate global commercialisation?